A common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older women

Clinica Chimica Acta

Volumn 396, Issue 1-2, 2008, Pages 70-75

  Moraes, Clayton F ^a   Souza, Elias R ^a   Souza, Vinícius C ^a   Medeiros, Eloá F F ^a   Gonçalves, Thiago F ^a   Toledo, Juliana O ^a   Karnikowski, Mauro ^a   Gomes, Lucy ^a   Karnikowski, Margô G O ^a   Córdova, Cláudio ^a   Nóbrega, Otávio T ^a  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

Brazil; Guidelines; Hypertension; Pharmacotherapy; Polymorphism; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; AGING; ALLELE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRAZIL; CLINICAL ASSESSMENT; COMMUNITY CARE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAZIL; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 50049124701     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.002     Document Type: Article

References (46)

1. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
2. Brazilian Health Ministry. URL:http://www.datasus.gov.br. Accessed in March 3rd, 2008.
3. Firdaus M., Sivaram C.A., and Reynolds D.W. Prevention of cardiovascular events by treating hypertension in older adults: an evidence-based approach. J Clin Hypertens (Greenwich) 10 (2008) 219-225
4. Garcez-Leme L.E., Leme M.D., and Espino D.V. Geriatrics in Brazil: a big country with big opportunities. J Am Geriatr Soc 53 (2005) 2018-2022
5. Karnikowski M.G., Nóbrega O.T., Naves J.O., and Silver L.D. Access to essential drugs in 11 Brazilian cities: a community-based evaluation and action method. J Public Health Policy 25 (2004) 288-298
6. Nóbrega O.T., Marques A.R., Araújo A.C., Karnikowski M.G., Naves J.O., and Silver L.D. Retail prices of essential drugs in Brazil: an international comparison. Rev Panam Salud Publica 22 (2007) 118-123
7. Naves J.O., and Silver L.D. Evaluation of pharmaceutical assistance in public primary care in Brasilia, Brazil. Rev Saude Publica 39 (2005) 223-230
8. Castellar J.I., Karnikowski M.G., Vianna L.G., and Nóbrega O.T. Study of the pharmacotherapy prescribed for older-adult in a Brazilian long-term care facility. Acta Med Port 20 (2007) 97-105
9. Cushman W.C., and Black H.R. Hypertension in the elderly. Cardiol Clin 17 (1999) 79-92
10. Ribeiro A.B., Zanella M.T., and Kohlmann Jr. O. Guidelines for treatment of hypertension in Latin America: the Brazilian experience. Clin Exp Hypertens 21 (1999) 683-692
11. Schunkert H., Hense H.W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330 (1994) 1634-1638
12. Kainulainen K., Perola M., Terwilliger J., et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33 (1999) 844-849
13. Franklin S.S. Hypertension in older people: part 1. J Clin Hypertens (Greenwich) 8 (2006) 444-449
14. Tonet A.C., Karnikowski M., Moraes C.F., et al. Association between the -174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 41 (2008) 47-53
15. IV Brazilian Guidelines in Arterial Hypertension Work Groups. IV Brazilian guidelines in arterial hypertension. Arq Bras Cardiol 82 Suppl 4 (2004) 7-22
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
18. Marre M., Jeunemaitre X., Gallois Y., et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99 (1997) 1585-1595
19. International Diabetes Federation. URL:http://www.idf.org/metabolic_syndrome. Accessed on March 3rd, 2008.
20. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20 (1992) 1433
21. Bonnardeaux A., Davies E., Jeunemaitre X., et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24 (1994) 63-69
22. Redon J., Chaves F.J., Liao Y., et al. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Hypertension 35 (2000) 490-495
23. Chaves F.J., Pascual J.M., Rovira E., Armengod M.E., and Redon J. Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension. Am J Hypertens 14 (2001) 364-370
24. Staessen J.A., Wang J.G., Ginocchio G., et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15 (1997) 1579-1592
25. Ntzani E.E., Rizos E.C., and Ioannidis J.P. Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol 165 (2007) 973-984
26. Arnett D.K., Claas S.A., and Glasser S.P. Pharmacogenetics of antihypertensive treatment. Vascul Pharmacol 44 (2006) 107-118
27. Mion Jr. D., da Silva G.V., de Gusmão J.L., et al. Do Brazilian physicians follow the Brazilian guidelines on hypertension?. Arq Bras Cardiol 88 (2007) 212-217
28. Dudley C., Keavney B., Casadei B., Conway J., Bird R., and Ratcliffe P. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens 14 (1996) 259-262
29. Mondorf U.F., Russ A., Wiesemann A., Herrero M., Oremek G., and Lenz T. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Am J Hypertens 11 (1998) 174-183
30. Harrap S.B., Tzourio C., Cambien F., et al. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 42 (2003) 297-303
31. Tiret L., Rigat B., Visvikis S., et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51 (1992) 197-205
32. Rieder M.J., Taylor S.L., Clark A.G., and Nickerson D.A. Sequence variation in the human angiotensin converting enzyme. Nat Genet 22 (1999) 59-62
33. Marrero A.R., Das Neves Leite F.P., De Almeida Carvalho B., et al. Heterogeneity of the genome ancestry of individuals classified as White in the state of Rio Grande do Sul, Brazil. Am J Hum Biol 17 (2005) 496-506
34. Lawes C.M., Bennett D.A., Feigin V.L., and Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 35 (2004) 776-785
35. Hingorani A.D., Jia H., Stevens P.A., Hopper R., Dickerson J.E., and Brown M.J. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13 (1995) 1602-1609
36. Katsuya T., Iwashima Y., Sugimoto K., et al. Effects of antihypertensive drugs and gene variants in the renin-angiotensin system. Hypertens Res 24 (2001) 463-467
37. Kurland L., Liljedahl U., Karlsson J., et al. Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Am J Hypertens 17 (2004) 8-13
38. Redon J., Luque-Otero M., Martell N., and Chaves F.J. POLPRI Investigators. Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients. Pharmacogenomics J 5 (2005) 14-20
39. Du Y., Yao A., Guo D., Inagami T., and Wang D.H. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension 25 (1995) 872-877
40. Abdollahi M.R., Gaunt T.R., Syddall H.E., et al. Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet 42 (2005) 396-401
41. O'Donnell C.J., Lindpaintner K., Larson M.G., et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (1998) 1766-1772
42. Milionis H.J., Kostapanos M.S., Vakalis K., et al. Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. J Renin Angiotensin Aldosterone Syst 8 (2007) 181-189
43. Karnikowski M., Córdova C., Oliveira R.J., Karnikowski M.G., and Nóbrega O.T. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J 125 (2007) 333-337
44. Morris B.J. Identification of essential hypertension genes. J Hypertens 11 (1993) 115-120
45. Krabbe K.S., Pedersen M., and Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 39 (2004) 687-699
46. Bogdarina I., Welham S., King P.J., Burns S.P., and Clark A.J. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 100 (2007) 520-526